1. Research Framework for Japan Pruritus Therapeutics Market

1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2. Research Methodology

2.1. Qualitative Research
2.1.1. Primary & Secondary Sources

2.2. Quantitative Research
2.2.1. Primary & Secondary Sources

2.3. Breakdown of Primary Research Respondents, By Region

2.4. Assumption for the Study

2.5. Market Size Estimation

2.6. Data Triangulation

3. Executive Summary: Japan Pruritus Therapeutics Market

Executive Summary: Japan Pruritus Therapeutics Market

4. Japan Pruritus Therapeutics Market Overview

4.1. Industry Value Chain Analysis
4.1.1. Raw Material Provider
4.1.2. Manufacturer
4.1.3. Distributor
4.1.4. End User

4.2. Industry Outlook
4.2.1. Recent Advances in Clinical Translation of Intra-Articular Osteoarthritis Drug Delivery Systems
4.2.2. Recent advances in hyaluronic acid-based therapy for osteoarthritis
4.2.3. Patient Data of Osteoarthritis in Japan

4.3. PESTLE Analysis

4.4. Porter's Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of Substitutes
4.4.4. Threat of New Entrants
4.4.5. Degree of Competition

4.5. Market Dynamics and Trends
4.5.1. Growth Drivers - Rising Geriatric Population
5.5.1.1. Enhanced Healthcare Spending Further Catalyzing the Japan Pruritus Therapeutics Market
4.5.2. Restraints
4.5.2.1. Pathophysiology Understanding is A Key Challenge in the Market
4.5.3. Opportunity
4.5.3.1. Technological Integration is Reshaping the Market 
4.5.4. Key Trends

4.6. Market Growth and Outlook
4.6.1. Market Revenue Estimates and Forecast (US$ Mn), 2025-2033
4.6.2. Price Trend Analysis

4.7. Competition Dashboard
4.7.1. Market Concentration Rate
4.7.2. Company Market Share Analysis (Value %), 2024
4.7.3. Competitor Mapping & Benchmarking

5. Japan Pruritus Therapeutics Market Analysis, By Drug Type

5.1. Key Insights

5.2. Market Size and Forecast, 2025 - 2033 (US$ Mn)
5.2.1. Corticosteroids 
5.2.2. Antihistamines 
5.2.3. Local Anaesthetics 
5.2.4. Counterirritants
5.3.5. Immunosuppressant
5.3.6. Calcineurin Inhibitors
5.3.7. Others

6. Japan Pruritus Therapeutics Market Analysis, By Disease Type

6.1. Key Insights

6.2. Market Size and Forecast, 2025 - 2033 (US$ Mn)
6.2.1. Atopic Dermatitis 
6.2.2. Allergic Contact Dermatitis 
6.2.3. Urticaria

7. Japan Pruritus Therapeutics Market Analysis, By Route of Administration

7.1. Key Insights

7.2. Market Size and Forecast, 2025 - 2033 (US$ Mn)
7.2.1. Oral 
7.2.2. Topical 
7.2.3. Parenteral

8. Japan Pruritus Therapeutics Market Analysis, By Distribution Channel

8.1. Key Insights

8.2. Market Size and Forecast, 2025 - 2033 (US$ Mn)
8.2.1. Hospital Pharmacies 
8.2.2. Online Pharmacies 
8.2.3. Retail Pharmacies

9. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

9.1. AbbVie 
9.2. Astellas .
9.3. Cara Therapeutics
9.4. Daiichi Sankyo
9.5. Eisai 
9.6. Kyowa Kirin 
9.7. Leo Pharma
9.8. Mitsubishi Tanabe Pharma
9.9. Maruho
9.10. Pfizer
9.11. Regeneron
9.12. Sanofi
9.13. Shionogi & Co
9.14. Sumitomo Dainippon